Your Location：
Home >
Browse articles >
Construction of a human Bax eukaryotic expression vector and its expression in human drug resistant gastric cancer cell line SGC7901/VCR
Updated：2026-03-12

    • Construction of a human Bax eukaryotic expression vector and its expression in human drug resistant gastric cancer cell line SGC7901/VCR

    • Military Medical Research   Vol. 0, Issue 3, Pages: 184-187(1999)
    • CLC： R735.2

    • Published：1999

    Scan QR Code

  • Construction of a human Bax eukaryotic expression vector and its expression in human drug resistant gastric cancer cell line SGC7901/VCR[J]. Military Medical Research1999, 0(3): 184-187. DOI：

  •  
  •  
icon
The trial reading is over, you can activate your VIP account to continue reading.
Deactivate >
icon
The trial reading is over. You can log in to your account, go to the personal center, purchase VIP membership, and read the full text.
Already a VIP member?
Log in >

0

Views

16

Downloads

0

CSCD

Alert me when the article has been cited
Submit
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Standardizing the classification of gastric cancer patients with limited and adequate number of retrieved lymph nodes: an externally validated approach using real-world data
Determination of telomerase activity and its clinical significance in gastric cancer and premalignant lesions
Blocking effect of hammerhead ribozyme RCP on HBV gene expression in HepG2215 cell line
Kanglaite combined Gemcitabine inhibits growth of nude mouse subcutaneous transplantation tumor of human PC-3 pancreatic cancer cell

Related Author

Wei Wang
Yu-Jie Yang
Ri-Hong Zhang
Jing-Yu Deng
Zhe Sun
Sharvesh Raj Seeruttun
Zhen-Ning Wang
Hui-Mian Xu

Related Institution

Department of Gastric Surgery, Sun Yat-sen University Cancer Center
State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine
Department of Gastric Cancer Surgery, Tianjin Medical University Cancer Institute and Hospital
Department of Surgical Oncology, the First Hospital of China Medical University
Department of General Surgery
0